Chapter title |
Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
|
---|---|
Chapter number | 409 |
Book title |
Induced Pluripotent Stem Cells and Human Disease
|
Published in |
Methods in molecular biology, June 2021
|
DOI | 10.1007/7651_2021_409 |
Pubmed ID | |
Book ISBNs |
978-1-07-162584-2, 978-1-07-162585-9
|
Authors |
Getachew, Heran, Chinchilla, Blanca, Fernandez-Godino, Rosario |
Abstract |
Genome editing with the use of CRISPR/Cas9 ribonucleoprotein complexes of induced pluripotent stem cells can be used to model many diseases. The combination of stem cells and gene editing technologies is a valuable tool to study ocular disorders, as many have been identified to be caused by specific genetic mutations. This protocol provides experimentally derived guidelines for genome editing of human induced pluripotent stem cells (iPSCs) using CRISPR/Cas9 ribonucleoprotein complexes to generate iPSCs harboring single nucleotide variants from ocular disorders. Edited iPSC can be further differentiated into retinal cells in order to study disease mechanisms as well as screen potential therapies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 10 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 30% |
Student > Postgraduate | 2 | 20% |
Unspecified | 1 | 10% |
Other | 1 | 10% |
Unknown | 3 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 3 | 30% |
Unspecified | 1 | 10% |
Neuroscience | 1 | 10% |
Engineering | 1 | 10% |
Unknown | 4 | 40% |